GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Capital Expenditure

Hanmi Science Co (XKRX:008930) Capital Expenditure : ₩-7,759.35 Mil (TTM As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Hanmi Science Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-1,250 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-7,759.35 Mil.

Hanmi Science Co Capital Expenditure Historical Data

The historical data trend for Hanmi Science Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Capital Expenditure Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,965.31 -1,950.84 -2,214.50 -8,342.39 -8,677.56

Hanmi Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,168.32 -1,741.31 -3,927.44 -840.50 -1,250.11

Hanmi Science Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,759.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hanmi Science Co (XKRX:008930) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Capital Expenditure
Comparable Companies
XKRX:003540 XKRX:036170 XKRX:001290 XKRX:030610 XKRX:034950 XKRX:001750 XKRX:001500 XKRX:023410 XKRX:039490 XKRX:001270 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459
Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Website
http://www.hanmi.co.kr
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines